WebPurpose: The objective of this study was to develop a pH-dependent calcium carbonate nano-delivery system for the combination therapy of CDDP with oleanolic acid (OA). Methods: A microemulsion method was employed to generate lipid coated cisplatin/oleanolic acid calcium carbonate nanoparticles (CDDP/OA-LCC NPs), and the … WebFeb 1, 2024 · Aim: Cisplatin (Cis) is widely used chemotherapeutic and has some serious side effects as nephrotoxicity. Phloretin (PH) and Phloridzin (PZ) are known their anti …
Did you know?
WebMar 26, 2024 · Stock solutions of cisplatin, indomethacin, flurbiprofen, [Ph 3 Sn (IND)], and [Ph 3 Sn (FBP)] were made in DMSO and subsequently diluted in growth medium to reach the following concentrations: 300, 100, 30, 10, 3, 1, and 0.1 μM for cisplatin, 100, 50, 25, 12.5, 6.25, 3.125, and 1.6 μM for the NSAIDs and 10, 5, 1, 0.5, 0.1, 0.01, and 0.001 μM … WebAug 21, 2024 · Intracellular pH (pHi) and energy metabolism are thought to contribute to the responses of cancer cells to chemotherapy with cisplatin. A “reversed” pH gradient with …
WebIt is soluble in water at a rate of approximately 14 mg/mL, and the pH of a 1% solution is 5 to 7. It is virtually insoluble in ethanol, acetone, and dimethylacetamide. CLINICAL … WebAug 5, 2024 · 3.2. In Vitro Cisplatin Release. As shown in Figures 3(a) and 3(b), the cisplatin release from HA-Cis and HA-mPEG-Cis NPs under different pH conditions was …
Web瑞禧生物提供科研级cisplatin-PEG-SCM 顺铂-聚乙二醇-琥珀酰亚胺乙酸酯,我们一直致力于研发纳米靶向科研产品以满足国内广大科研院校及其他相关科研单位的需求。cisplatin-PEG-SCM 顺铂-聚乙二醇-琥珀酰亚胺乙酸酯试剂不能用于人体治疗、药物开发、和其他商业用途。 Web(sis-PLA-tin) Cisplatin is a chemotherapy drug that contains the metal platinum. It stops or slows growth of cancer cells and other cells that grow rapidly by damaging their DNA. …
WebAug 5, 2024 · 3.2. In Vitro Cisplatin Release. As shown in Figures 3(a) and 3(b), the cisplatin release from HA-Cis and HA-mPEG-Cis NPs under different pH conditions was evaluated.In the physiological conditions of blood circulation (), the cisplatin release was the lowest in both NPs.With pH decreasing from 6.8 (tumor microenvironment) to 5.5 …
WebOct 5, 2014 · Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. ... Willemse PH, De Vries EG, Kampinga HH, Van der Zee AG. Heat-shock-protein-27 (hsp27) expression in … mmo chessWebCisplatin ˃0.4 mg/mL Cyclophosphamide: Apply cold compress for 15 to 20 minutes at least 4 times/day for the first 24 to 48 hours: Sodium thiosulfate: Daunorubicin Doxorubicin … mmoclusterWebAug 10, 2024 · Purpose: The phase II single-arm KEYNOTE-052 study evaluated the efficacy and safety of first-line pembrolizumab for patients with locally advanced or metastatic cisplatin-ineligible urothelial carcinoma (UC). Patients and methods: Three hundred seventy patients received pembrolizumab 200 mg intravenously every 3 weeks … mmo characterWebCisplatin (PIM 132) Cisplatin 1. NAME 1.1 Substance 1.2 Group 1.3 Synonyms 1.4 Identification Numbers 1.4.1 CAS 1.4.2 Other Numbers 1.5 Brand Names, Trade Names 1.6 Manufacturers, Importers 1.7 Presentation, Formulation 2. SUMMARY 2.1 Main Risks and Target Organs 2.2 Summary of Clinical Effects 2.3 Diagnosis initial photo id paWebJun 23, 2024 · If it is possible to load cisplatin during crystallization, ZIF-11 would outcompete the other MOFs screened as cisplatin cannot pass through its pore windows; therefore, release rates would be purely driven by the pH triggered framework degradation. I. INTRODUCTION mmo burnoutWebDosisnya 75–100 mg/m2 luas permukaan tubuh (LPT) per siklus, tiap 4 minggu. Obat ini akan dikombinasikan dengan cyclophosphamide. Kondisi: Kanker testis yang sudah menyebar. Dosisnya 20 mg/m2 LPT selama 5 hari per siklus. Dosis akan diulangi kembali tiap 3 minggu. Obat akan dikombinasikan dengan bleomycin dan etoposide. mmoc borcaWeb** to adjust pH Ingredient(s) indicated as hazardous have been assessed under standards for workplace safety. 3. HAZARDS IDENTIFICATION ... Material Name: Cisplatin … initial phosphorylation of glucose atp